6 months

Regulatory News

Headline Date Type Company Source
Immunovia publishes the Annual Report for 2024 02-Apr-25 07:39 Company Announcement - General Immunovia Ab PR Newswire
The exercise period for warrants series TO 3 begins today 01-Apr-25 07:45 Company Announcement - General Immunovia Ab PR Newswire
Warrant Extension, Debt Conversion & Equity Issue 01-Apr-25 07:01 Company Announcement - General Immupharma RNS
Extension of Warrants in Incanthera to 30 Sep 2025 01-Apr-25 07:01 Company Announcement - General Immupharma RNS
Immunovia announces determined exercise price for warrants series TO 3 27-Mar-25 20:27 Company Announcement - General Immunovia Ab PR Newswire
Immunovia provides further positive data from the VERIFI study of its next-generation pancreatic cancer test 24-Mar-25 15:32 Non-Regulatory News Immunovia Ab PR Newswire
Immunovia to host a webcast to share more data from the successful VERIFI clinical validation study 21-Mar-25 12:39 Company Announcement - General Immunovia Ab PR Newswire
Immunovia announces another successful clinical validation of its next-generation pancreatic cancer test 19-Mar-25 12:29 Non-Regulatory News Immunovia Ab PR Newswire
ImmuPharma proves unique Mechanism of Action-P140 13-Mar-25 07:01 Company Announcement - General Immupharma RNS
Immunovia's CLARITI study results selected for prestigious presentation at the world's largest gastroenterology conference 03-Mar-25 07:48 Non-Regulatory News Immunovia Ab PR Newswire
Immunovia Publishes Full Year Report for 2024 25-Feb-25 08:54 Results and Trading Reports Immunovia Ab PR Newswire
Immunovia initiates search for a new CFO to support commercialization in the USA 21-Feb-25 17:04 Executive Changes Immunovia Ab PR Newswire
Holding(s) in Company 21-Feb-25 12:43 Holding(s) in Company Immupharma RNS
Invitation to Immunovia's Q4 presentation 21-Feb-25 09:05 Non-Regulatory News Immunovia Ab PR Newswire
£2.91m fundraising; related party transactions 13-Feb-25 07:01 Company Announcement - General Immupharma RNS
Change in number of shares and votes in Immunovia AB (publ) 31-Jan-25 10:35 Company Announcement - General Immunovia Ab PR Newswire
Change in number of shares and votes in Immunovia AB (publ) 31-Jan-25 10:31 Company Announcement - General Immunovia Ab PR Newswire
Response to Share Price Movement 28-Jan-25 12:57 Company Announcement - General Immupharma RNS
Immunovia AB announces outcome of exercise of warrants series TO 2 20-Jan-25 10:58 Company Announcement - General Immunovia Ab PR Newswire
Immunovia AB announces outcome of exercise of warrants series TO 2 20-Jan-25 10:55 Company Announcement - General Immunovia Ab PR Newswire
Breakthrough Findings into Autoimmune Diseases 09-Jan-25 07:01 Company Announcement - General Immupharma RNS
Immunovia AB (Publ) presents Nomination Committee 08-Jan-25 12:58 Company Announcement - General Immunovia Ab PR Newswire
Immunovia AB (Publ) presents Nomination Committee 08-Jan-25 12:56 Company Announcement - General Immunovia Ab PR Newswire
The exercise period for warrants of series TO 2 beings today: Immunovia AB 02-Jan-25 07:46 Company Announcement - General Immunovia Ab PR Newswire
The exercise period for warrants of series TO 2 beings today: Immunovia AB 02-Jan-25 07:43 Company Announcement - General Immunovia Ab PR Newswire